Home/Protocols/PE-22-28
Protocol Reference
HEALING

PE-22-28 (10 mg vial)

Once daily subcutaneous protocol for tissue-repair research.

PE-22-28 is a fragment of spadin that modulates the TREK-1 potassium channel, studied preclinically for neuroplasticity and mood. Effective amounts are tiny and human data is absent. The protocol below uses low once-daily subcutaneous doses.

Quick answer: at the standard 10 mg + 1 mL reconstitution, a 200 mcg dose of PE-22-28 draws 2 units (0.02 mL) on a U-100 insulin syringe, once daily subcutaneous.

Category
Healing & Repair
Common vials
Not stocked by our featured supplier
Half-life
Not established in humans
Route in the literature
Not established

Protocol overview

Goal
A shortened analog of spadin, which blocks the TREK-1 potassium channel. Rodent work studies it for rapid antidepress...
Schedule
Once daily subcutaneous, 8-16 weeks
Reconstitution
10 mg vial + 1 mL bac water (10 mg/mL)
Storage
Lyophilized: frozen or 2-8 °C; reconstituted: refrigerated, use within 28 days
Evidence
The published work on this compound is animal or cell-culture research. No human dosing schedule exists to cite.

Dosing & reconstitution

Community-reported ranges. These are the amounts commonly reported in user communities and vendor protocols, not from controlled human trials. They are listed here because they are what most people reference in practice.

Frequency: Once daily subcutaneous
Typical duration: 8-16 weeks

Reconstitution: 10 mg vial + 1 mL bacteriostatic water = 10 mg/mL. Units below are for a U-100 insulin syringe at this concentration.

PhaseDoseUnits per injection
Weeks 1-250 mcg0.5 units (0.005 mL)
Weeks 3-8100 mcg1 unit (0.01 mL)
Weeks 9-12150 mcg1.5 units (0.015 mL)
Weeks 13-16200 mcg2 units (0.02 mL)

Units = (dose ÷ concentration) × 100 on a U-100 syringe. Change the vial size or water volume and the calculator redoes all of this for you.

Track this protocol → Free account · log doses, rotate sites, never lose your history

PE-22-28 dosing — what the literature actually supports

Animal data only. PE-22-28 has been studied in rodents only. There is no human trial, no pharmacokinetic data in humans, and no citable schedule.

We publish a schedule when there is a citable human source and we say so when there is not. Filling this space with a number nobody measured would make the page look more complete and be worth less than nothing to you.

Reconstitution and measurement

This part is arithmetic and does not depend on the evidence level. Concentration is vial size divided by the bacteriostatic water you add. Draw volume is your target amount divided by that concentration. Units are draw volume times 100, because a U-100 syringe reads 100 units per millilitre. Common vials for PE-22-28: Not stocked by our featured supplier.

  1. Wipe the stoppers of both vials with an alcohol swab and let them dry.
  2. Draw the bacteriostatic water with a sterile syringe and inject it slowly down the inside wall of the peptide vial — never straight onto the powder.
  3. Swirl gently until the solution is clear. Do not shake; foaming and agitation damage peptides.
  4. Label the vial with the date and concentration, and refrigerate at 2–8 °C protected from light.

Open the PE-22-28 calculator → Unit converter

Storage and stability

Dry powder
Cold, dark and dry. Lyophilized peptide is the stable form — keep it that way until you intend to use it.
After reconstitution
Refrigerate at 2–8 °C, protect from light, and plan around a limited window. Do not freeze a reconstituted vial — freeze-thaw damages peptides.
Mixing
Run bacteriostatic water down the inside wall of the vial rather than onto the powder, then swirl. Never shake.
Inspect before use
A clear solution is expected. Cloudiness or particles mean discard, not use.

Full storage guide → · Cloudy solution?

Important notes

Practical considerations for consistency and safety.

  • Use a new sterile insulin syringe for each injection and dispose in a proper sharps container.
  • Inject slowly and steadily; wait a few seconds before withdrawing the needle to ensure complete delivery.
  • Administer at the same time each day for consistent levels. Setting a daily reminder helps maintain the schedule.
  • This compound lacks controlled human safety data. Start with the lowest reported amount and increase gradually while monitoring for any adverse reactions.
  • The 10 mg vial size is standard for this compound. Reconstitute with 1 mL bacteriostatic water for a convenient concentration.

How PE-22-28 works

A shortened analog of spadin, which blocks the TREK-1 potassium channel. Rodent work studies it for rapid antidepressant-like effects and for synaptogenesis.

Benefits & side effects

Potential benefits

  • Derived from PEDF with neuroprotective properties
  • Promotes neurogenesis in preclinical models
  • Anti-inflammatory effects reported
  • Very low dose requirements

Possible side effects

  • Very limited human data
  • Injection site reactions
  • Extremely low doses used
  • Preclinical safety profile only

This list reflects published literature and community reports. Individual responses vary. Not medical advice.

Bloodwork worth tracking

The community-standard practice is a baseline panel before starting, a recheck 8 to 12 weeks in, and another after time off. For PE-22-28, the markers most worth watching:

CMPCBC

Typical time off: 4 wks

Lab panels are how a research protocol stays honest: numbers move before symptoms do. Interpretation belongs with a clinician. Not medical advice.

Lifestyle factors

None of the literature above was run on a background of poor sleep and no protein. These variables move outcomes more reliably than any compound on this site.

  • Protein in the 1.6 to 2.2 g/kg range preserves lean mass through any body-composition phase.
  • Resistance training 2 to 4 days per week plus 150+ minutes of weekly aerobic work reinforces whatever the protocol is doing.
  • Sleep is the recovery window: 7 to 9 hours at consistent times.
  • Hydration matters more than usual on compounds with GI or flushing effects: 2 to 3 liters daily.
  • Track the variables that matter: weigh-ins, measurements, photos, and labs at sensible intervals.

Quick answers

How many syringe units is a 200 mcg dose of PE-22-28?

At the standard reconstitution of 10 mg with 1 mL bacteriostatic water (10 mg/mL), a 200 mcg dose draws 2 units (0.02 mL) on a U-100 insulin syringe.

How do you reconstitute PE-22-28?

Add 1 mL of bacteriostatic water to the 10 mg vial for 10 mg/mL. Inject the water slowly down the inside wall of the vial, swirl gently without shaking, and refrigerate at 2 to 8 °C after mixing.

How long does a 10 mg vial of PE-22-28 last?

About 50 maintenance doses of 200 mcg, roughly 7.1 weeks at once daily subcutaneous.

Does PE-22-28 have human trial data?

No. The evidence base is animal and cell studies; the practical dosing shown is community convention, and the page labels it that way.

How does PE-22-28 work?

A shortened analog of spadin, which blocks the TREK-1 potassium channel. Rodent work studies it for rapid antidepressant-like effects and for synaptogenesis.

Sourcing PE-22-28

Our featured supplier does not stock this compound, and we are not going to point you at a vendor we have not looked at. Use the COA checklist on whoever you do buy from, and check the batch number on the certificate against the vial you receive.

COA checklist → How we vet suppliers

For laboratory research use only. This page documents what the published literature reports about PE-22-28. It is not a recommendation, not a treatment plan, and not medical advice. Compounds referenced are sold strictly as research chemicals and are not for human or veterinary use. Some supplier links are affiliate links and may earn us a commission. This never affects tier placement or review conclusions.
Summit Research Supply
Summit Research Supply — COA-verified research peptidesThird-party tested · U.S. fulfillment · new researchers save 10%
Shop →